70 related articles for article (PubMed ID: 2798996)
1. [Evaluation of the therapeutic efficacy of aztreonam in the treatment of infection caused by sensitive microorganisms].
Tirone F; Musca G; Filomia D; Vigna L
Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):85-8. PubMed ID: 2798996
[TBL] [Abstract][Full Text] [Related]
2. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
3. [Aztreonam and aminoglycosides in the therapy of urinary infections associated with renal calculosis].
Coen G; Nazzaro L; Cipriani P; Giordano A; Mazzaferro S; Petta S; Reale MG; Smacchi A
Clin Ter; 1989 Feb; 128(4):243-9. PubMed ID: 2524313
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
Raz R; Flatau E; Sudarsky M; Keness J
Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
[TBL] [Abstract][Full Text] [Related]
7. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
[TBL] [Abstract][Full Text] [Related]
8. Aztreonam in the therapy of severe gram-negative infections.
Davies A; Stone J; Hassan A; Quarty P; Green T
Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
[No Abstract] [Full Text] [Related]
9. Role of aztreonam in lower respiratory tract infections.
Cook JL
Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of aztreonam in the prevention and therapy of infections in patients subjected to neurosurgical intervention].
Donati PA; Gallicchio B; Maiuri F; Gangemi M; D'Andrea F
Minerva Med; 1987 Aug; 78(16):1227-30. PubMed ID: 3627533
[TBL] [Abstract][Full Text] [Related]
11. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the clinical effectiveness of aztreonam in gram-negative infections of the biliary tract].
Pedretti G; Magnani G
G Ital Chemioter; 1988; 35(1-3):45-8. PubMed ID: 3256512
[No Abstract] [Full Text] [Related]
13. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
[TBL] [Abstract][Full Text] [Related]
14. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of aztreonam for complicated urinary tract infection].
Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
[TBL] [Abstract][Full Text] [Related]
16. In-vitro susceptibility to aztreonam.
Lim VK
Malays J Pathol; 1988 Aug; 10():61-4. PubMed ID: 3252078
[No Abstract] [Full Text] [Related]
17. [Aztreonam: monocenter microbiological study with prevention experience in surgery].
Malcangi A; Pesce S; Vitale M; Martinetto P
G Batteriol Virol Immunol; 1987; 80(1-12):237-51. PubMed ID: 3509031
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with aztreonam of gram negative infections in patients seropositive for HIV].
Catania S; Mascellino MT; Trinchieri V; Musso R; Lorenzi A; Cirelli A
Riv Eur Sci Med Farmacol; 1988 Aug; 10(4):317-21. PubMed ID: 3274906
[No Abstract] [Full Text] [Related]
19. [Is aztreonam could become "a challenger" for treatment of Gram negative infections? May be an answer from microbiological data: in vitro study including 36,485 strains of enterobacteria and Pseudomonas].
Honderlick P; Gravisse J; Dardelle D; Cahen P
Pathol Biol (Paris); 2007 Dec; 55(10):475-7. PubMed ID: 17904768
[TBL] [Abstract][Full Text] [Related]
20. Treatment of infections during hematologic malignancies with aztreonam, a new antibiotic.
Rizzo SC; Ricevuti G; Invernizzi R; Mazzone A; Nastasi G
Chemioterapia; 1986 Dec; 5(6):400-3. PubMed ID: 3802302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
